Formation of estrogen-DNA adducts plays a critical role in the initiation of ovarian cancer. »
07/10/13

Deletion of cathepsin S inhibited tumor growth and development. »
11/07/13

YEATS4 as a candidate oncogene amplified in NSCLC. »
10/31/13

2ME2 combined with pan-PI3K inhibitors seen as potential treatment for intractable brain cancer. »
08/12/13

miR-361-5p is an oncomicroRNA and an important factor in the progression of cervical cancer. »
09/19/13

To develop a multiplexed pseudovirion-based serological assay (PsV-Luminex) encompassing 21 HPV types and validate the method by correlating the serology with the presence of type specific HPV DNA in cervical samples. »
10/19/12

Dacomitinib exhibited pronounced activity both as single-agent and when combined with chemotherapy in human bladder cancer models. »
10/30/13

Significant increase of endometrial cancer risks were observed in Caucasians and studies consistent with HWE. »
11/03/13

Evaluation of potency preservation and sexual function following SBRT for prostate cancer. »
11/01/13

Development of a pathology reporting form for more precise research on melanoma and a diagnostic-treatment mapping tool for improved patient care and consistency in treatment. »
03/28/13